Why the study?
Does implantation of programmable dual A-V sequential demand (DVI,MN) pacemakers improve the recognition and termination of tachycardias in patients with drug-refractory A-V reciprocating tachycardias?
Population
8 patients with recurrent or incessant, drug-refractory, A-V reciprocating tachycardias involving various…
Design
Case_series
Follow-up
4 to 20 months
Authors
Loading...
May aid select refractory cases; leaves open need for controlled trials before wider use.
Does implantation of programmable dual A-V sequential demand (DVI,MN) pacemakers improve the recognition and termination of tachycardias in patients with drug-refractory A-V reciprocating tachycardias?
Programmable dual A-V sequential demand pacemakers are effective and safe for automatically terminating drug-refractory A-V reciprocating tachycardias, reducing the need for antiarrhythmic medications.
Portillo et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: